fda drug shortage list semaglutide What's New in Obesity Treatment? FDA declares end to Wegovy

13 While GLP-1 agonist-induced weight loss can decrease mechanical load through the musculoskeletal system and improve aspects of physical function, the resulting negative effects on tendons, impaired muscle function, and joint degradation can persist after a healthy weight has been achieved

[DOI] [PMC free article] [PubMed] [Google Scholar] 13.GBD 2017 Causes of Death Collaborators

Theyve been hailed as game-changers for weight management, diabetes, and even heart and liver health

Cost and Accessibility As a newer medication, tirzepatide may be more expensive than semaglutide in some regions

The aims of this study included determining the effect of semaglutide treatment on SBP in patients with hypertension, SBP in patients with RH, SBP when baseline body mass index (BMI) is considered, and alterations to anti-hypertensive medications